- Full Year 2023 Biomerieux SA Earnings Call TranscriptMar 14, 2024$108.55Earnings
- Q3 2023 Biomerieux SA Corporate Sales Call TranscriptOct 26, 2023
- Half Year 2023 Biomerieux SA Earnings Call TranscriptSep 01, 2023$104.25Earnings
- Biomerieux SA Evolution of Biomerieux's Governance Call TranscriptJun 14, 2023
- Q1 2023 Biomerieux SA Corporate Sales Call TranscriptApr 27, 2023
- Full Year 2022 Biomerieux SA Earnings Call TranscriptMar 08, 2023$95.68Earnings
- Q3 2022 Biomerieux SA Corporate Sales Call TranscriptOct 26, 2022
- Half Year 2022 Biomerieux SA Earnings Call TranscriptAug 31, 2022$91.9 (-10.53%)Earnings
- Q1 2022 Biomerieux SA Business Results Call TranscriptApr 12, 2022
- Full Year 2021 Biomerieux SA Earnings Call TranscriptMar 02, 2022$96.8 (-10.20%)Earnings
- Q3 2021 Biomerieux SA Business Review Call TranscriptOct 21, 2021
- Half Year 2021 Biomerieux SA Earnings Call TranscriptSep 01, 2021$124.65Earnings
- Q1 2021 Biomerieux SA Business Review TranscriptApr 27, 2021
- Full Year 2020 Biomerieux SA Earnings Call TranscriptFeb 24, 2021$132.88 (-0.09%)Earnings
- Q3 2020 Biomerieux SA Business Review Call TranscriptOct 22, 2020
- Half Year 2020 Biomerieux SA Earnings Call TranscriptSep 02, 2020$144.75 (-3.50%)Earnings
- Q1 2020 Biomerieux SA Corporate Sales Call TranscriptApr 16, 2020
- Full Year 2019 Biomerieux SA Earnings Call TranscriptFeb 26, 2020$94.71 (-3.60%)Earnings
- Q3 2019 Biomerieux SA Business Review Call TranscriptOct 22, 2019
- Half Year 2019 Biomerieux SA Earnings Call TranscriptSep 04, 2019$81.82 (+1.51%)Earnings
- Q1 2019 Biomerieux SA Corporate Sales Call TranscriptApr 24, 2019
- Full Year 2018 Biomerieux SA Earnings Call TranscriptFeb 27, 2019$82.8 (+4.28%)Earnings
Half Year 2023 Biomerieux SA Earnings Call Transcript
Good day, and welcome to the bioMérieux H1 2023 Financial Performance Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Aymeric Fichet. Please go ahead.
Thanks a lot, Kelly. So hello, everyone. Good afternoon, good morning, and thank you for joining us to review bioMérieux's performance for the first half of 2023. I'm on line with Pierre Boulud, CEO; and Guillaume Bouhours, CFO.
Before handing the call over to Pierre for preliminary remarks, please note that this conference call will include forward-looking statements. I would like to remind you of the usual disclaimer saying that forward-looking statements are based entirely or partially on assessments or judgments that may change or be modified due to uncertainties and risks related to the company's environment. I also remind you that today's call is being recorded and that a replay will be available on our website, www.biomerieux-finance.com. I will now
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)